ArticleInternational urology and nephrology2026
Lower urinary tract symptoms after laser enucleation of the prostate in patients with and without preoperative indwelling catheter.
Article in International urology and nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Rates and Predictors of Persistent LUTS Medication Use After Laser Enucleation of the Prostate.Lower urinary tract symptoms · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo test for differences in outcomes of lower urinary tract symptoms (LUTS) between patients with and without preoperative indwelling catheter after laser enucleation of the prostate (LEP).
methodsIn our tertiary-care database, patients undergoing LEP (11/2017-09/2023) were retrospectively analyzed, stratified by presence of preoperative catheter. Mixed linear models assessed International Prostate Symptom Score (IPSS) and quality of life (QoL) at 1, 3, 12, and 24 months after LEP. Multiple linear regression, adjusted for age and prostate volume, tested for differences in LUTS and QoL recovery.
resultsAmong 518 patients, 132 (25%) had a catheter before LEP (89% transurethral, 11% suprapubic), mainly due to acute urinary retention (82%). Mean catheter duration was 13 weeks; 48% exceeded 12 weeks. Catheter patients were older (71 vs. 69 years, p = 0.003), had higher PSA (8.3 vs. 5.8 ng/ml, p < 0.001), and larger prostate volume (98 vs. 86 ml, p = 0.004). At 1 month, catheter patients reported lower IPSS (7.1 vs. 9.8) and more favorable QoL (1.6 vs. 2.3). No significant differences were seen at 3, 12, and 24 months in adjusted IPSS. In regression analyses, preoperative catheter was associated with improved IPSS at 1 (coefficient -2.8, p < 0.001), 3 (-2.6, p < 0.001), and 12 months (-1.8, p = 0.007), as well as better QoL at 1 (beta -0.8, p < 0.001), 3 (-0.7, p < 0.001), and 12 months (-0.4, p = 0.01).
conclusionPatients with preoperative catheterization appear to experience similar long-term benefits from LEP compared to those without catheter, but show greater improvements in LUTS and QoL within the first postoperative year.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.